Levosimendan Attenuates Electrical Alternans and Prevents Ventricular Arrhythmia during Therapeutic Hypothermia in Isolated Rabbit Hearts.

[1]  C. Callaway,et al.  Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. , 2021, The New England journal of medicine.

[2]  M. Lo,et al.  Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia , 2020, PloS one.

[3]  L. Eckardt,et al.  Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model. , 2017, International journal of cardiology.

[4]  L. Eckardt,et al.  Experimental evidence for a severe proarrhythmic potential of levosimendan. , 2017, International journal of cardiology.

[5]  A. Cohen-Solal,et al.  The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion Nieminen, , 2022 .

[6]  B. Larsen,et al.  Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts. , 2016, Heart rhythm.

[7]  J. Villa,et al.  Post myocardial infarction left bundle branch block disappearing with levosimendan , 2015 .

[8]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[9]  J. Weiss,et al.  Apamin‐Sensitive Calcium‐Activated Potassium Currents in Rabbit Ventricles with Chronic Myocardial Infarction , 2013, Journal of cardiovascular electrophysiology.

[10]  B. Massie,et al.  Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. , 2013, JACC. Heart failure.

[11]  Changyu Shen,et al.  Apamin-Sensitive Potassium Current Modulates Action Potential Duration Restitution and Arrhythmogenesis of Failing Rabbit Ventricles , 2013, Circulation. Arrhythmia and electrophysiology.

[12]  Ruben Coronel,et al.  Repolarization gradients in the intact heart: transmural or apico-basal? , 2012, Progress in biophysics and molecular biology.

[13]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[14]  C. Ting,et al.  Therapeutic hypothermia (30 degrees C) enhances arrhythmogenic substrates, including spatially discordant alternans, and facilitates pacing-induced ventricular fibrillation in isolated rabbit hearts. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[15]  A. Cohen-Solal,et al.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.

[16]  Trine Krogh-Madsen,et al.  Action potential duration dispersion and alternans in simulated heterogeneous cardiac tissue with a structural barrier. , 2007, Biophysical journal.

[17]  M. Kupari,et al.  Duration of the haemodynamic action of a 24‐h infusion of levosimendan in patients with congestive heart failure , 2007, European journal of heart failure.

[18]  Z. Yao,et al.  Effect of temperature on the activation of myocardial KATP channel in guinea pig ventricular myocytes: a pilot study by whole cell patch clamp recording. , 2006, Chinese medical journal.

[19]  A. Garfinkel,et al.  From Pulsus to Pulseless: The Saga of Cardiac Alternans , 2006, Circulation research.

[20]  C. Antzelevitch.  Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem? , 2004, Journal of electrocardiology.

[21]  P. Pollesello,et al.  Potassium-specific effects of levosimendan on heart mitochondria. , 2004, Biochemical pharmacology.

[22]  J. Cleland,et al.  Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.

[23]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[24]  A Hofman,et al.  The prognosis of heart failure in the general population: The Rotterdam Study. , 2001, European heart journal.

[25]  A. Garfinkel,et al.  Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. , 1999, Circulation.

[26]  D. Rosenbaum,et al.  Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. , 1999, Circulation.

[27]  M. Sunagawa,et al.  The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells. , 1997, The Journal of pharmacology and experimental therapeutics.